Wird geladen...
Inactivation of mTORC2 in macrophages is a signature of colorectal cancer that promotes tumorigenesis
The mechanistic target of rapamycin complex 2 (mTORC2) is a potentially novel and promising anticancer target due to its critical roles in proliferation, apoptosis, and metabolic reprogramming of cancer cells. However, the activity and function of mTORC2 in distinct cells within malignant tissue in...
Gespeichert in:
| Veröffentlicht in: | JCI Insight |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Clinical Investigation
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6824305/ https://ncbi.nlm.nih.gov/pubmed/31619583 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.124164 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|